Development and validation of a simple and sensitive size-exclusion chromatography method for quantitative determination of heparin in pharmaceuticals
Heparin is widely used as an anticoagulant for the treatment and prevention of various thrombotic diseases. However, due to its high anionic charge, heterogeneity in size distribution and high polarity, its analysis is very challenging. In this paper, a novel method based on size-exclusion chromatog...
Saved in:
Main Authors: | Matanović Maja Radivojša, Grabnarm Iztok, Grabnar Pegi Ahlin, Roškar Robert |
---|---|
Format: | Article |
Language: | English |
Published: |
Sciendo
2015-03-01
|
Series: | Acta Pharmaceutica |
Subjects: | |
Online Access: | https://doi.org/10.1515/acph-2015-0010 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Size exclusion chromatography as green support for forced degradation study of adalimumab
by: Kovačić Jelena, et al.
Published: (2023-12-01) -
Thromboelastography for rapid diagnosis of heparin-like anticoagulant release during anaphylaxis-induced coagulopathy in systemic mastocytosis: a case report
by: Rajkumar Rajendram, et al.
Published: (2025-01-01) -
The Effect of Exercise on Pharmacodynamics and Pharmacokinetics of a Single Dose of Unfractionated Heparin—A Randomized, Controlled, Crossover Study
by: Liva K. Stuhr, et al.
Published: (2025-01-01) -
Organic matter from biofilter nitrification by high performance size exclusion chromatography and fluorescence excitation-emission matrix
by: E.N. Hidayah, et al.
Published: (2020-04-01) -
A new biocompatible delivery scaffold containing heparin and bone morphogenetic protein 2
by: Thanyaphoo Suphannee, et al.
Published: (2016-09-01)